Gene · 338412
TAS2R64P: taste 2 receptor member 64, pseudogene
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. TAS2R64P: taste 2 receptor member 64, pseudogene. Genes, record 338412. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/338412
On this page
Gene
Proteins0
Reviewed human proteins whose Swiss-Prot entry states the gene.
None in this release.
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants1,233
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | TAS2R64P papers | Newest fiscal year |
|---|---|---|---|
| P30CA016672 | Cancer Center Support Grant | 9 | 2025 |
| P30CA008748 | Cancer Center Support Grant | 7 | 2025 |
| P30CA051008 | Georgetown University Lombardi Comprehensive Cancer Center Support Grant | 7 | 2025 |
| R01CA072038 | Replication Stress and DNA Damage Response Drives ESR1 Mutant Metastasis | 5 | 2025 |
| R01HD007857 | Sex Hormone Receptor Component And The Cell Genome | 4 | 2025 |
| R01HD008188 | Reproductive Hormones - Biological and Molecular Actions | 4 | 2025 |
| ZIAAG000311 | ALZHEIMERS RESEARCH PROJECT: Design And Development Of Experimental Therapeutics ((Systemic & Neurodegenerative Disorders and Alzheimer's Disease) | 4 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 3 | 2025 |
| P30CA046934 | University of Colorado Cancer Center Support Grant | 3 | 2025 |
| R01CA200669 | Estrogen Receptor and NFkB Crosstalk in Breast Cancer | 3 | 2025 |
1 to 10 of 1,233Source NIH's project files
See all 1,233 nih grantsPapers2,231
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Isolated gastrointestinal hereditary angioedema associated with a pathogenic SERPING1 variant arising de novo: a case report. | Front Med (Lausanne) | 2026 | 42755627 | PubTator, text mining | PubMed |
| Hydrophobic Modification of Cotton Fabrics with Epoxy-Functional Polysiloxanes: Comparison of Direct Deposition and Thiol-Crosslinked Coating. | Materials (Basel) | 2026 | 42654532 | PubTator, text mining | PubMed |
| Physicochemical convergence in antibody CDR3-VH repertoires recognizing phosphorothioate-modified oligonucleotides backbone. | Front Immunol | 2026 | 42292354 | PubTator, text mining | PubMed |
| Comparative Evaluation of the Effect of Different Polishing Systems on Surface Roughness of Permanent 3D-Printed Resins and a CAD/CAM Restorative Material. | J Esthet Restor Dent | 2026 | 42233319 | PubTator, text mining | PubMed |
| Early-onset renal amyloidosis associated with psoriasis in a child with cryopyrinopathy: a case report. | BMC Pediatr | 2026 | 42163195 | PubTator, text mining | PubMed |
| Progesterone resistance in atypical endometrial hyperplasia: Expression and mechanisms of hormone-responsive molecules. | Medicine (Baltimore) | 2026 | 42065161 | PubTator, text mining | PubMed |
| The Regulation and Function of Hippo/YAP Pathway in Cancer. | FASEB J | 2026 | 41924992 | PubTator, text mining | PubMed |
| Dexamethasone Suppresses Already Low Estrogen Receptor Levels in Meningiomas. | Int J Mol Sci | 2026 | 41898640 | PubTator, text mining | PubMed |
| The JMJD family histone demethylases: structure, mechanism of action, diseases and therapeutic targets. | Mol Biomed | 2026 | 41857315 | PubTator, text mining | PubMed |
| Treatment with Mirvetuximab-Soravtansin-first clinical experience in advanced ovarian cancer in a comprehensive cancer center. | Front Oncol | 2026 | 41800034 | PubTator, text mining | PubMed |
1 to 10 of 2,231
See all 2,231 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/338412
GET https://conductscience.org/api/genes/v1/338412/grants?page=2